depression treatment
FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its own. It was approved in 2019 to treat severe depression.
Tiny fish on ketamine may show how drug eases depression
In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps people with depression.
